Isobavachalcone: an overview.
10.1007/s11655-012-1142-7
- Author:
Victor KUETE
1
;
Louis P SANDJO
Author Information
1. Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, Cameroon. kuetevictor@yahoo.fr
- Publication Type:Journal Article
- MeSH:
Animals;
Biosynthetic Pathways;
drug effects;
Cell Death;
drug effects;
Chalcones;
biosynthesis;
chemistry;
pharmacology;
Humans
- From:
Chinese journal of integrative medicine
2012;18(7):543-547
- CountryChina
- Language:English
-
Abstract:
Isobavachalcone (IBC) or (E)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)-phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one or (E)-4,2',4'-trihydroxy-3'-prenylchalcone; 2',4,4'-trihydroxy-3'-prenyl-transchalcone, is a prenylated chalcone of the class flavonoid, firstly isolated from Psoralea corylifolia in 1968. IBC is known to possess a wide spectrum of biological activities, antibacterial, antifungal, anticancer, anti-reverse transcriptase, antitubercular and antioxidant. The compound was isolated from plant families, mostly Moraceae and Fabaceae. This review brings out together the knowledge on IBC, and can serve as the start point for future research and valorization accomplishments.
